Terragen Secures Major Feedlot Supply Agreement and Cattle Trial
Terragen Holdings Limited (ASX: TGH) has entered into its first large-scale commercial agreement for the supply of its Terragen Probiotic for Ruminants (TPR) and Great Land Plus (GLP) products with Ravensworth Feedlot in New South Wales. The deal includes a minimum commitment of 360,000 doses, with deliveries expected to begin in late 2026 across large cattle operations.
In addition, Meat & Livestock Australia Donor Company and Mort & Co are supporting a large commercial trial involving more than 10,000 cattle to examine the impact of TPR Ultra on feed efficiency, carcass quality, and overall meat performance. The trial is expected to commence in June 2026 at one of Australia’s largest feedlots.
Terragen believes these developments highlight the growing commercial acceptance of its biological agricultural products and could support stronger revenue growth in the coming years while promoting more sustainable livestock production practices.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events. Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Terragen Secures Major Feedlot Supply Agreement and Cattle Trial
Terragen Holdings Limited (ASX: TGH) has entered into its first large-scale commercial agreement for the supply of its Terragen Probiotic for Ruminants (TPR) and Great Land Plus (GLP) products with Ravensworth Feedlot in New South Wales. The deal includes a minimum commitment of 360,000 doses, with deliveries expected to begin in late 2026 across large cattle operations.
In addition, Meat & Livestock Australia Donor Company and Mort & Co are supporting a large commercial trial involving more than 10,000 cattle to examine the impact of TPR Ultra on feed efficiency, carcass quality, and overall meat performance. The trial is expected to commence in June 2026 at one of Australia’s largest feedlots.
Terragen believes these developments highlight the growing commercial acceptance of its biological agricultural products and could support stronger revenue growth in the coming years while promoting more sustainable livestock production practices.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events. Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au